H. Iven
- Transplantation top 5%
-
- Acute Lymphoblastic Leukemia research 14
- Pregnancy and Medication Impact 5
- Speech and Hearing top 5%
- Hematology top 5%
-
- Ion channel regulation and function 6
-
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Chronic Lymphocytic Leukemia Research 3
-
- Cardiac electrophysiology and arrhythmias 3
-
- Acute Kidney Injury Research 3
-
- Muscle activation and electromyography studies 3
- Co-authors
- Helmut BraschG. ZetlerRaja AtreyaMohammad Reza AhmadianKai HildnerDennis StrandChristoph BeckerBrigitte Bartsch
- Journals
- Naunyn-Schmiedeberg s Archives of Pharmacology (10 papers)European Journal of Clinical Pharmacology (7 papers)Cancer Chemotherapy and Pharmacology (6 papers)
- Partner nations
- GermanyUnited StatesPoland
In The Last Decade
H. Iven
58 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Transplantation 90
- Public Health, Environmental and Occupational Health 749
- Speech and Hearing 119
- Hematology 161
- Pediatrics, Perinatology and Child Health 279
Countries citing papers authored by H. Iven
This map shows the geographic impact of H. Iven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Iven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Iven more than expected).
Fields of papers citing papers by H. Iven
This network shows the impact of papers produced by H. Iven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Iven. The network helps show where H. Iven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. Iven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2006 | 6 | |
| 3 | 2005 | 9 | |
| 4 | CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytesbreakdown → | 2003 | 634 |
| 5 | 2003 | 4 | |
| 6 | 2002 | 15 | |
| 7 | 2002 | 27 | |
| 8 | 2000 | 20 | |
| 9 | 1999 | 24 | |
| 10 | 1999 | 17 | |
| 11 | 1998 | 61 | |
| 12 | 1997 | 317 | |
| 13 | 1997 | 13 | |
| 14 | 1992 | 3 | |
| 15 | 1991 | 22 | |
| 16 | 1991 | 25 | |
| 17 | 1990 | 1 | |
| 18 | 1989 | 3 | |
| 19 | 1989 | 20 | |
| 20 | 1988 | 12 |
About H. Iven
H. Iven is a scholar working on Nephrology, Transplantation and Pharmacology, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (14 papers), Ion channel regulation and function (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Pregnancy and Medication Impact (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cardiac electrophysiology and arrhythmias (3 papers), Acute Kidney Injury Research (3 papers) and Muscle activation and electromyography studies (3 papers). The work is most often cited by research in Transplantation (90 citations), Public Health, Environmental and Occupational Health (749 citations) and Speech and Hearing (119 citations). H. Iven has collaborated with scholars based in Germany, United States and Poland. Frequent co-authors include Helmut Brasch, G. Zetler, Raja Atreya, Mohammad Reza Ahmadian, Kai Hildner, Dennis Strand, Christoph Becker, Brigitte Bartsch, Richard S. Blumberg and Jonas Mudter. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, European Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, Pharmacology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.